JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue71,64437,197-
Cost of Revenue---
Gross Profit71,64437,197-
Operating Expenses
Research Development67,79834,90422,130
Selling General and Administrative23,06116,7598,266
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-19,215-14,466-30,396
Income from Continuing Operations
Total Other Income/Expenses Net2,8087631,864
Earnings Before Interest and Taxes-16,407-13,703-28,532
Interest Expense---
Income Before Tax-16,407-13,703-28,532
Income Tax Expense36--
Minority Interest---
Net Income From Continuing Ops-16,443-13,703-28,532
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-16,443-13,703-28,532
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-17,237-23,138-37,503